Preemptive Therapy of GVHD

NCT01994824 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
70
Enrollment
OTHER
Sponsor class

Stopped The trend was observed toward higher mortality among the patients receiving the intervention Thymoglobulin on day 8 after hematopoietic cell transplantation.

Conditions

Interventions

Sponsor

University of Calgary

Collaborators